Amicus Therapeutics Inc (FOLD) financials · rev $634.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Amicus Therapeutics Inc (FOLD) rev $634.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $634.2M | $528.3M |
| Cost of Revenue | $72.9M | $52.9M |
| Gross Profit | $561.3M | $475.4M |
| Operating Income | $32.8M | $24.9M |
| Net Income | -$27.1M | -$56.1M |
| EPS (Diluted) | -$0.09 | -$0.18 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $949.9M | $785.0M |
| Current Assets | $676.2M | $504.7M |
| Cash & Equivalents | $214.0M | $213.8M |
| Inventory | $228.8M | $118.8M |
| PP&E | $27.1M | $29.4M |
| Total Liabilities | $675.6M | $591.0M |
| Current Liabilities | $237.8M | $148.7M |
| Long-term Debt | $392.7M | $390.1M |
| Total Debt | $392.7M† | $390.1M† |
| Shareholders' Equity | $274.2M | $194.0M |
| Retained Earnings | -$2.77B | -$2.74B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $33.1M | -$33.9M |
| CapEx | $3.30M | $3.55M |
| Investing Cash Flow | -$46.4M | -$560.0K |
| Financing Cash Flow | $610.0K | $5.12M |
| Net Change in Cash | $600.0K | -$33.4M |
| Free Cash Flow | $29.8M | -$37.4M |
FAQ
What is FOLD P/E and revenue?
Amicus Therapeutics Inc (FOLD) rev $634.2M.
What is FOLD revenue?
Amicus Therapeutics Inc last cached revenue is $634.2M (FY2025).
Is FOLD profitable?
Amicus Therapeutics Inc last cached net income is -$27.1M (FY2025).
What are FOLD total assets?
Amicus Therapeutics Inc last cached total assets are $949.9M (FY2025).
What is FOLD free cash flow?
Amicus Therapeutics Inc last cached free cash flow is $29.8M (FY2025).
Not investment advice. Cached statements, not a live tape.